Predictors of Oral Function and Facial Aesthetics Post Maxillofacial Reconstruction with Free Fibula Flap
Overview
Affiliations
Background: For maxillofacial reconstruction, free flaps have largely replaced pedicled flaps. In a Saudi Arabian sample, we (1) assessed patients' postoperative oral function and facial aesthetics (OFFA), specifically pertaining to diet, speech intelligibility, oral opening, maxilla-mandibular occlusion, and facial aesthetics (all rated 0-2) following fibular free flap surgery; and (2) identified preoperative predictors of a novel 10-point OFFA rating scale combining these 5 parameters.
Methods: We conducted a retrospective review of the medical records of all patients who underwent free fibula flap surgery for nontraumatic maxillofacial reconstruction from 2010 to 2017 and were followed postoperatively for at least 6 months or until death.
Results: In 20 patients (10 female; mean age, 33.8; range, 7-56), the results were excellent, 19 of 20 patients ultimately resuming a normal diet, one a soft diet; good oral opening in 18; and normal speech, normal occlusion, and an aesthetically good result, each in 17 patients. Half the patients had a perfect (10/10) OFFA score at final assessment, whereas 2 scored 9/10, one 8/10, and two 6/10. On univariate analysis, patient age > 45, tumor of higher malignancy potential, comorbid illness, and adjuvant radiotherapy predicted a worse OFFA score, whereas a multivariate model combining comorbid illness ( = 0.002) and preoperative radiotherapy ( = 0.010) predicted a lower OFFA score, accounting for 57% of the variance (R = 0.57).
Conclusion: In Saudi Arabia, fibular free flaps yielded overall very good to excellent results in 19 of 20 patients undergoing nontraumatic maxillofacial reconstruction.
Kurosawa K, Ohkoshi A, Ishii R, Sato N, Miyashita H, Harata T JPRAS Open. 2024; 42:350-360.
PMID: 39583297 PMC: 11582545. DOI: 10.1016/j.jpra.2024.10.002.
Nguyen K J Surg Case Rep. 2023; 2023(6):rjad394.
PMID: 37397071 PMC: 10308916. DOI: 10.1093/jscr/rjad394.
Puricelli E, Chem R Head Face Med. 2021; 17(1):46.
PMID: 34711252 PMC: 8554960. DOI: 10.1186/s13005-021-00293-z.